SP1 and colorectal cancer: Finally, studies of prostate and colorectal cancers have demonstrated that miR-375 may participate in chemoresistance through interactions with Yes-associated protein 1 (YAP1) and Specificity Protein 1 (SP1) transcription factors [38,39].